QuantaMatrix Inc.

QuantaMatrix is an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture.

Its portfolio also includes QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis, QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease, and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. Founded in 2010, QuantaMatrix is based in Seoul, South Korea.